
What We're Reading: Generic Pricing Probe; EpiPen Coverage; Mass. Insurers to Merge
Generic drug makers are being accused of blocking a Congressional probe into their pricing practices; Illinois has become the first state to require insurance companies to pay for EpiPens for kids in cases of severe allergic reactions; Tufts Health Plan and Harvard Pilgrim Health will merge to create a new company covering 2.4 million people across New England.
Generic Drug Makers Accused of Obstructing Congressional Probe
Senator Bernie Sanders, I-Vermont, and Representative Elijah Cummings, D-Maryland, are renewing an investigation into Teva Pharmaceutical Industries, Mylan NV, and Heritage Pharmaceuticals based on allegations of “apparent coordinated obstruction” in failing to provide lawmakers information about their pricing practices. Sanders and Cummings sent letters to the drug makers, renewing their 2014 request,
Illinois Will Require Insurers to Cover EpiPen for Kids
Illinois has become the first state to require insurance companies to pay for EpiPens for kids in cases of severe allergic reactions,
Two of Massachusetts’ Largest Insurers to Merge
Tufts Health Plan and Harvard Pilgrim Health have announced plans to merge to create a new company covering 2.4 million people across New England. The combined company will span 5 states and offer both private coverage and Medicare and Medicaid plans. The 2 insurers have tried to merge in the past, including in 2011, but the attempts eventually fell through. According to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.